Standout Papers

KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stroma... 2006 2026 2012 2019 642
  1. KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours (2006)
    Maria Dêbiec‐Rychter, Raf Sciot et al. European Journal of Cancer

Immediate Impact

1 by Nobel laureates 3 from Science/Nature 61 standout
Sub-graph 1 of 19

Citing Papers

Renal Cell Carcinoma
2024 Standout
Renal cell carcinoma
2024 Standout

Works of M. Schlemmer being referenced

Imaging in Suspected Renal-Cell Carcinoma: Systematic Review
2018

Author Peers

Author Last Decade Papers Cites
M. Schlemmer 2168 1979 1211 61 3.1k
Satvinder Mudan 2116 2061 1801 90 3.6k
Masato Hanada 2403 2692 1580 50 3.9k
Pekka Tervahartiala 1435 1034 1111 68 3.1k
Sonja E. Steigen 1353 1317 1058 54 2.4k
A. Kevin Raymond 1580 786 624 49 2.3k
Kirsten Sundby Hall 2325 703 1050 103 3.3k
Michael A. Burgess 1396 652 691 46 2.7k
C Charnsangavej 1971 678 1303 66 3.8k
Jeffrey D. Wayne 1553 1332 1399 65 3.4k
Michael T. Mazur 1323 708 1017 62 3.1k

All Works

Loading papers...

Rankless by CCL
2026